 |
PDBsum entry 2k2j
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase, signaling protein
|
PDB id
|
|
|
|
2k2j
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase, signaling protein
|
 |
|
Title:
|
 |
Nmr solution structure of the split ph domain from phospholipasE C gamma 2
|
|
Structure:
|
 |
1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-2. Chain: a. Fragment: ph domains (unp residues 471-514 and 850-913). Synonym: phosphoinositide phospholipasE C, plc-gamma-2, phospholipasE C-gamma-2, plc-iv. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Gene: plcg2. Expressed in: escherichia coli.
|
|
NMR struc:
|
 |
20 models
|
 |
|
Authors:
|
 |
R.Harris,T.D.Bunney,M.Katan,P.C.Driscoll
|
Key ref:
|
 |
C.Walliser
et al.
(2008).
Rac Regulates Its Effector Phospholipase C{gamma}2 through Interaction with a Split Pleckstrin Homology Domain.
J Biol Chem,
283,
30351-30362.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
02-Apr-08
|
Release date:
|
09-Sep-08
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P16885
(PLCG2_HUMAN) -
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
1265 a.a.
117 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 38 residue positions (black
crosses)
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.1.4.11
- phosphoinositide phospholipase C.
|
|
 |
 |
 |
 |
 |

Pathway:
|
 |
myo-Inositol Phosphate Metabolism
|
 |
 |
 |
 |
 |
Reaction:
|
 |
a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate) + H2O = 1D-myo-inositol 1,4,5-trisphosphate + a 1,2-diacyl-sn-glycerol + H+
|
 |
 |
 |
 |
 |
1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate)
|
+
|
H2O
|
=
|
1D-myo-inositol 1,4,5-trisphosphate
|
+
|
1,2-diacyl-sn-glycerol
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
J Biol Chem
283:30351-30362
(2008)
|
|
PubMed id:
|
|
|
|
|
| |
|
Rac Regulates Its Effector Phospholipase C{gamma}2 through Interaction with a Split Pleckstrin Homology Domain.
|
|
C.Walliser,
M.Retlich,
R.Harris,
K.L.Everett,
M.B.Josephs,
P.Vatter,
D.Esposito,
P.C.Driscoll,
M.Katan,
P.Gierschik,
T.D.Bunney.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Several isoforms of phospholipase C (PLC) are regulated through interactions
with Ras superfamily GTPases, including Rac proteins. Interestingly, of two
closely related PLCgamma isoforms, only PLCgamma(2) has previously been shown to
be activated by Rac. Here, we explore the molecular basis of this interaction as
well as the structural properties of PLCgamma(2) required for activation. Based
on reconstitution experiments with isolated PLCgamma variants and Rac2, we show
that an unusual pleckstrin homology (PH) domain, designated as the split PH
domain (spPH), is both necessary and sufficient to effect activation of
PLCgamma(2) by Rac2. We also demonstrate that Rac2 directly binds to PLCgamma(2)
as well as to the isolated spPH of this isoform. Furthermore, through the use of
NMR spectroscopy and mutational analysis, we determine the structure of spPH,
define the structural features of spPH required for Rac interaction, and
identify critical amino acid residues at the interaction interface. We further
discuss parallels and differences between PLCgamma(1) and PLCgamma(2) and the
implications of our findings for their respective signaling roles.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 3.
The role of the N-terminal and split PH domains of PLCγ[2]
in cellular activation by Rac2. Left, COS-7 cells were
transfected with increasing amounts per well of vector encoding
wild-type or mutant PLCγ isozymes. The total amount of DNA was
maintained constant in each transfection by adding empty vector.
The empty vector (control) (A and B) and the vectors encoding
PLCγ2-222, PLCγ2-212, PLCγ2-221, and PLCγ2-211 (B) were used
only at 1000 ng/well, since there were only minimal changes in
inositol phosphate production even at this high amount of vector
DNA. Under these conditions, the inositol phosphate formation in
B was as follows: control, 223 ± 30 cpm; PLCγ2-222, 436
± 67 cpm; PLCγ2-212, 390 ± 59 cpm; PLCγ2-221,
348 ± 54 cpm; PLCγ2-211, 360 ± 6 cpm (mean
± S.D. of triplicate determinations). [^3H]Inositol
phosphate accumulation was measured as described under
“Experimental Procedures.” Right, COS-7 cells were
cotransfected as indicated with empty vector (control) and/or
vectors encoding Rac2, Rac2^G12V, or either wild-type or mutant
PLCγ isozymes. The amounts of vectors encoding the PLCγ
isozymes were adjusted according to their basal activities shown
in the left panels (PLCγ1-111 and PLCγ1-211, 300 ng/well;
PLCγ1-112, 100 ng/well; PLCγ1-121 and PLCγ1-122, 10 ng/well;
all other vectors, 1000 ng per well). The total amount of DNA
was maintained constant in each transfection by adding empty
vector. In additional experiments (results not shown), we found
that expression of Rac2^G12V also caused only a minor
(≤1.9-fold) stimulation of inositol phosphate formation in
cells cotransfected with 1000 ng/well of vector encoding
PLCγ1-111 or PLCγ1-211.
|
 |
Figure 5.
Surface charge distribution of PLCγ[1] and PLCγ[2] spPHs.
Surface electrostatic potentials representations of these two
spPHs were computed with PyMol (top, PLCγ[2] spPH; bottom,
PLCγ[1] spPH). Electrostatic potentials are represented as
positive (blue), negative (red), and neutral (white) charges.
The large loop that links the two parts of the spPHs (which is
present in the published NMR structure of the PLCγ[1] spPH) is
not shown. The N view notation refers to the surface derived
from the amino acid residues from the N-terminal half of the
domain, and the C view refers to those residues derived from the
C-terminal part.
|
 |
|
|
|
| |
The above figures are
reprinted
from an Open Access publication published by the ASBMB:
J Biol Chem
(2008,
283,
30351-30362)
copyright 2008.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
K.Abe,
H.Fuchs,
A.Boersma,
W.Hans,
P.Yu,
S.Kalaydjiev,
M.Klaften,
T.Adler,
J.Calzada-Wack,
I.Mossbrugger,
B.Rathkolb,
J.Rozman,
C.Prehn,
M.Maraslioglu,
Y.Kametani,
S.Shimada,
J.Adamski,
D.H.Busch,
I.Esposito,
M.Klingenspor,
E.Wolf,
W.Wurst,
V.Gailus-Durner,
M.Katan,
S.Marschall,
D.Soewarto,
S.Wagner,
and
M.H.de Angelis
(2011).
A novel N-ethyl-N-nitrosourea-induced mutation in phospholipase Cγ2 causes inflammatory arthritis, metabolic defects, and male infertility in vitro in a murine model.
|
| |
Arthritis Rheum,
63,
1301-1311.
|
 |
|
|
|
|
 |
T.D.Bunney,
and
M.Katan
(2011).
PLC regulation: emerging pictures for molecular mechanisms.
|
| |
Trends Biochem Sci,
36,
88-96.
|
 |
|
|
|
|
 |
A.Y.Pollitt,
B.Grygielska,
B.Leblond,
L.Désiré,
J.A.Eble,
and
S.P.Watson
(2010).
Phosphorylation of CLEC-2 is dependent on lipid rafts, actin polymerization, secondary mediators, and Rac.
|
| |
Blood,
115,
2938-2946.
|
 |
|
|
|
|
 |
M.Yamashita,
K.Kurokawa,
Y.Sato,
A.Yamagata,
H.Mimura,
A.Yoshikawa,
K.Sato,
A.Nakano,
and
S.Fukai
(2010).
Structural basis for the Rho- and phosphoinositide-dependent localization of the exocyst subunit Sec3.
|
| |
Nat Struct Mol Biol,
17,
180-186.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.L.Rich,
and
D.G.Myszka
(2010).
Grading the commercial optical biosensor literature-Class of 2008: 'The Mighty Binders'.
|
| |
J Mol Recognit,
23,
1.
|
 |
|
|
|
|
 |
V.Cremasco,
E.Benasciutti,
M.Cella,
M.Kisseleva,
M.Croke,
and
R.Faccio
(2010).
Phospholipase C gamma 2 is critical for development of a murine model of inflammatory arthritis by affecting actin dynamics in dendritic cells.
|
| |
PLoS One,
5,
e8909.
|
 |
|
|
|
|
 |
K.L.Everett,
T.D.Bunney,
Y.Yoon,
F.Rodrigues-Lima,
R.Harris,
P.C.Driscoll,
K.Abe,
H.Fuchs,
M.H.de Angelis,
P.Yu,
W.Cho,
and
M.Katan
(2009).
Characterization of phospholipase C gamma enzymes with gain-of-function mutations.
|
| |
J Biol Chem,
284,
23083-23093.
|
 |
|
|
|
|
 |
T.D.Bunney,
O.Opaleye,
S.M.Roe,
P.Vatter,
R.W.Baxendale,
C.Walliser,
K.L.Everett,
M.B.Josephs,
C.Christow,
F.Rodrigues-Lima,
P.Gierschik,
L.H.Pearl,
and
M.Katan
(2009).
Structural insights into formation of an active signaling complex between Rac and phospholipase C gamma 2.
|
| |
Mol Cell,
34,
223-233.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
T.K.Harden,
S.N.Hicks,
and
J.Sondek
(2009).
Phospholipase C isozymes as effectors of Ras superfamily GTPases.
|
| |
J Lipid Res,
50,
S243-S248.
|
 |
|
|
|
|
 |
Z.Jakus,
E.Simon,
D.Frommhold,
M.Sperandio,
and
A.Mócsai
(2009).
Critical role of phospholipase Cgamma2 in integrin and Fc receptor-mediated neutrophil functions and the effector phase of autoimmune arthritis.
|
| |
J Exp Med,
206,
577-593.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |